Related references
Note: Only part of the references are listed.IgG replacement therapy, no size fits all
Francisco A. Bonilla
CLINICAL IMMUNOLOGY (2011)
Pharmacokinetics of subcutaneous immunoglobulin and their use in dosing of replacement therapy in patients with primary immunodeficiencies
Melvin Berger et al.
CLINICAL IMMUNOLOGY (2011)
Use of intravenous immunoglobulins in clinical practice: data from three French university hospitals
Elisabeth Frauger et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2011)
Immunoglobulin treatment in primary antibody deficiency
L. J. Maarschalk-Ellerbroek et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Incidence of Infection is Inversely Related to Steady-State (Trough) Serum IgG Level in Studies of Subcutaneous IgG in PIDD
Melvin Berger
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Pharmacokinetics and safety of subcutaneous immune globulin (human), 10% caprylate/chromatography purified in patients with primary immunodeficiency disease
R. L. Wasserman et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and Immunology
Pierre L. Yong et al.
CLINICAL IMMUNOLOGY (2010)
Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years
Mary Lucas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency
John B. Hagan et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
The Use of Immunoglobulin Therapy for Patients With Primary Immune Deficiency: An Evidence-Based Practice Guideline
Nadine Shehata et al.
TRANSFUSION MEDICINE REVIEWS (2010)
The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008
B. Gathmann et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Biologic IgG level in primary immunodeficiency disease: The IgG level that protects against recurrent infection
Vincent R. Bonagura et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases
Hans D. Ochs et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
K Darabi et al.
TRANSFUSION (2006)
Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
JS Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Rapid subcutaneous IgG replacement therapy is effective and safe in children and adults with primary immunodeficiencies -: A prospective, multi-national study
Ann Gardulf et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2006)
The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia - A randomized, double-blind, multicenter crossover trial
HW Eijkhout et al.
ANNALS OF INTERNAL MEDICINE (2001)
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
HM Chapel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2000)
A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers
C Chen et al.
ANNALS OF PHARMACOTHERAPY (2000)
Share Paper
